|
GTPBP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24830000003406E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.90450000000708E-05 |
| Normal-vs-Stage2 |
7.827400E-04 |
| Normal-vs-Stage3 |
1.1515000000184E-06 |
| Normal-vs-Stage4 |
2.56430000000751E-06 |
| Stage1-vs-Stage2 |
7.762800E-01 |
| Stage1-vs-Stage3 |
1.088210E-01 |
| Stage1-vs-Stage4 |
1.843830E-01 |
| Stage2-vs-Stage3 |
4.281000E-01 |
| Stage2-vs-Stage4 |
4.231800E-01 |
| Stage3-vs-Stage4 |
9.427800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82220000000122E-06 |
| Normal-vs-AfricanAmerican |
9.472200E-02 |
| Normal-vs-Asian |
8.823600E-04 |
| Caucasian-vs-AfricanAmerican |
1.439850E-01 |
| Caucasian-vs-Asian |
6.746800E-01 |
| AfricanAmerican-vs-Asian |
3.188200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02369999979801E-07 |
| Normal-vs-Female |
1.94531999999636E-05 |
| Male-vs-Female |
5.863700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.173200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.07829999995701E-06 |
| Normal-vs-Age(61-80Yrs) |
1.69419999995757E-06 |
| Normal-vs-Age(81-100Yrs) |
5.247700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.354180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.903440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.196200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.825800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.057800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.793800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.892400E-01 |
| Classical-VS-Follicular |
3.597900E-02 |
| Classical-VS-Other |
2.019800E-01 |
| Classical-VS-Normal |
5.56219999999774E-05 |
| Tall-VS-Follicular |
6.668800E-01 |
| Tall-VS-Other |
5.395800E-01 |
| Tall-VS-Normal |
5.422000E-04 |
| Follicular-VS-Other |
7.379400E-01 |
| Follicular-VS-Normal |
1.83350000004801E-06 |
| Other-VS-Normal |
7.298400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67870000017589E-07 |
| Normal-vs-N1 |
5.89469999999759E-05 |
| N0-vs-N1 |
6.963000E-01 |
|
|
